|
CS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.149200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.143000E-01 |
| Normal-vs-Stage2 |
4.316800E-01 |
| Normal-vs-Stage3 |
6.194000E-01 |
| Normal-vs-Stage4 |
5.551800E-01 |
| Stage1-vs-Stage2 |
4.457800E-01 |
| Stage1-vs-Stage3 |
6.837200E-01 |
| Stage1-vs-Stage4 |
6.208800E-01 |
| Stage2-vs-Stage3 |
7.670200E-01 |
| Stage2-vs-Stage4 |
9.458400E-01 |
| Stage3-vs-Stage4 |
8.576400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.438600E-01 |
| Normal-vs-AfricanAmerican |
1.571560E-01 |
| Normal-vs-Asian |
9.070400E-01 |
| Caucasian-vs-AfricanAmerican |
2.571000E-01 |
| Caucasian-vs-Asian |
8.573600E-01 |
| AfricanAmerican-vs-Asian |
5.610400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.105000E-01 |
| Normal-vs-Female |
2.087200E-01 |
| Male-vs-Female |
3.230200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.993000E-01 |
| Normal-vs-Extreme_Weight |
5.955800E-01 |
| Normal-vs-Obese |
4.680800E-01 |
| Normal-vs-Extreme_Obese |
4.456000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.929400E-01 |
| Normal_Weight-vs-Obese |
4.704000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.693600E-01 |
| Extreme_Weight-vs-Obese |
3.243200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.059200E-01 |
| Obese-vs-Extreme_Obese |
5.545800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.111400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.365400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.243000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.288400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.392000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.605200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.929800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.910600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.050000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.323200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.811400E-01 |
| Normal-VS-Type2 PRCC |
3.182600E-01 |
| Normal-VS-KIRP CIMP |
2.629000E-01 |
| Normal-VS-Unclassified PRCC |
5.524000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.729200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.082000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.696500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.064800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.850040E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.906000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.347200E-01 |
| Normal-vs-N1 |
8.391000E-01 |
| Normal-vs-N2 |
4.121800E-01 |
| N0-vs-N1 |
6.948400E-01 |
| N0-vs-N2 |
2.839000E-01 |
| N1-vs-N2 |
4.575000E-01 |
|
|
